Satsuma Pharmaceuticals, Inc.
STSA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $23 | $30 | $191 | $131 |
| - Cash | $20 | $16 | $41 | $24 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $14 | $151 | $107 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$11 | -$15 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$10 | -$23 | -$15 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.68 | -0.47 | -0.51 |
| % Growth | 55.9% | -44.7% | 7.8% | – |
| Operating Cash Flow | -$11 | -$12 | -$13 | -$12 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$11 | -$12 | -$13 | -$12 |